The 8th Annual CAR–TCR Summit is uniting experts with one common goal of engineering a disease–free world. Across this three–day event over one thousand attendees from over three hundred companies will all be coming together to explore discovery through to commercialization to deliver safe, effective and commercially viable CAR and TCR therapies.
September 1, 2023 | 8:50am
"Congratulations on Your Successful Phase 1, Now What?"
Presnted by: Eytan Abraham, VP & Business Head of Emerging Modalities
Join us to learn about:
Maturing your program into later stage with the right manufacturing partner
Launching your cell therapy in a commercial-ready supply chain network (vertical integration)
Leveraging the Resilience network to help you progress your program